ArticleJournal of experimental & clinical cancer research : CR2020

Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.